Skip to content
Search

Latest Stories

Half of Mumbai's slum residents have had coronavirus: study

Over half the people living in the slums of Mumbai have had the coronavirus, according to a city-commissioned study released Tuesday that raises fresh doubts about India's official case numbers.

India is already the third worst-hit country after the US and Brazil, with nearly 1.5 million cases though experts have previously said the lack of testing could mean the true tally is much higher.


Blood tests on 6,936 randomly selected people conducted by Mumbai's city authorities found that 57 percent of slum-dwellers and 16 percent of non-slum residents had virus antibodies.

Mumbai, where about 40 percent of the population lives in slums, has reported just over 110,000 infections and more than 6,000 deaths so far.

The western city of 20 million people is home to India's largest slum Dharavi, where an estimated one million people live.

But deaths in the sprawling slum have not exploded, with local officials saying their aggressive efforts to stem the spread of the virus has been effective.

The survey results suggested asymptomatic infections were "likely to be a high proportion of all infections" and also indicated the virus death rate was likely to be "very low", the study said.

The Mumbai survey came a week after an antibody study commissioned by the government suggested that almost a quarter of people in the capital New Delhi, home to 20 million people, have had the virus.

More For You

Minorities in England face 'lower prescribing rates for diabetes tech'

The disparity is particularly concerning as approximately 5.8 m people across the UK live with diabetes

iStock

Minorities in England face 'lower prescribing rates for diabetes tech'

Highlights

  • Ethnic minorities are less likely to receive continuous glucose monitors despite having higher diabetes rates.
  • People from minority backgrounds make up 17.5 per cent of populations in areas with below-average device prescribing.
  • Ethnicity and deprivation account for up to 77 per cent of variance in diabetes technology prescribing.

People from ethnic minority backgrounds in England have significantly less access to vital diabetes technology, despite being at greater risk of developing the condition, according to groundbreaking research.

The study, published in Diabetic Medicine, reveals that black and south Asian communities face significantly lower prescribing rates for continuous glucose monitors (CGMs) – devices that help people manage their blood glucose levels more effectively than traditional finger-prick tests.

Keep ReadingShow less